en

PRODUCT DETAIL

Xydalba 500 mg prášok na infúzny koncentrát

Code 4075B
MA number EU/1/14/986/001
Product Form: plc ifc 1x500 mg (liek.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: AbbVie Deutschland GmbH & Co. KG, Germany
Therapeutic Class: 15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01X OTHER ANTIBACTERIALS
J01XA Glycopeptide antibacterials
J01XA04 Dalbavancin
Shelf life: 48
Container: glass container
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 19.02.2015
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 22.06.2022
eu-flag.png sk-flag.png